Wyeth Licenses Osteoporosis Drug Targets From Galapagos
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth agrees to second milestone stemming from 2003 agreement, selecting three novel Galapagos targets for osteoporosis.